Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway

Fig. 5

Activated RHOA contributes to the regulation of ARHGAP30/β-catenin in pancreatic cancer. a RHOA activity was detected in ARHGAP30-overexpressing ASPC1 cells using western blotting. b RHOA activity was detected in ARHGAP30-silenced SW1990 cells using western blotting. c β-Catenin was detected using western blotting in cells subjected to ARHGAP30 knockdown and CCG-1423 (RHOA inhibitor) treatment. **p < 0.01, ***p < 0.001 vs. vector or shNC; ###p < 0.001 vs. shARHGAP30

Back to article page